葛兰素史克Glaxosmithkline plc (GSK) 2017年年度报告「LSE」.pdf

1、Annual Report2017Image HIV virusGSK Annual Report 2017Cover image30 years after developing the first HIV medicine,our research into treatment and prevention of HIV continues.We remain at the forefront of helping people living with HIV,driving innovation and working with communities all over the worl

2、d.Cautionary statementSee the inside back cover of this document for the cautionary statement regarding forward-looking statements.GSK is a science-led global healthcare companyIn the Strategic reportOur new CEO discusses 2017 performance and our new long-term priorities See pages 0507Measuring perf

3、ormance and managing risk See pages 1821Financial review See pages 5278How our three businesses together contribute to our Trust priority See pages 4251How we create long-term value See pages 0809Our new long-term priorities:Innovation,Performance and Trust See pages 1217Innovation and Performance i

4、n each of our three businesses See pages 2241Industry trends See pages 1011GSK Annual Report 201701Investor informationFinancial statementsGovernance and remunerationStrategic reportGSK Annual Report 201701Investor informationFinancial statementsGovernance and remunerationStrategic reportStrategic r

5、eportAt a glance 02Chairmans statement 04CEOs statement 05How we create long-term value 08Industry trends 10 Our long-term priorities 12How we measure success 18How we manage risk 20Pharmaceuticals 22Vaccines 30 Consumer Healthcare 36 Trust 42Group financial review 52GovernanceChairmans Governance s

6、tatement 80Our Board 82Our Corporate Executive Team 86Leadership and effectiveness 88Nominations Committee report 94Accountability 96Audit&Risk Committee report 96Relations with stakeholders 107Science Committee report 109Corporate Responsibility Committee report 110Remuneration reportChairmans annu